Policy and Medicine Archive for August, 2021

Click a link below to view the mailing archive as if it had been sent to you.

2021-08-31 12:30		Amgen Receives Untitled Letter for Banner Ad Promoting Neulasta
2021-08-30 12:30		CMS Proposes Rescinding Most Favored Nation Pricing Model
2021-08-28 12:30		Rockpointe Presents Online CME Course on Treating High-Risk Patients with COVID-19
2021-08-27 12:30		Telemedicine Executive Charged with Orchestrating Health Care Fraud
2021-08-26 12:30		Part D Spending Continues to Increase
2021-08-25 12:30		Legislation Introduced to Require Controlled Substance Providers Complete Continuing Education
2021-08-24 12:30		FDA Releases Draft Guidance on Sponsor Safety Reporting Requirements
2021-08-23 12:30		Government Intervenes in False Claims Act Suit Against Kaiser
2021-08-20 12:30		Xavier Becerra Supports Continued Use of Telehealth
2021-08-19 12:30		Interim Final Rule Released on Surprise Billing and Out-of-Network Charges
2021-08-18 12:30		Pfizer Agrees to Pay $345 Million to Resolve EpiPen Anti-Competitive Allegations
2021-08-17 12:30		Most Hospitals Not Abiding by Transparency Rule
2021-08-16 12:30		Congress to Investigate Aduhelm Approval
2021-08-14 12:30		August 2021 Issue P&M Compliance Update features interview with Creator of California AB-1278 Open Payments Transparency Bill
2021-08-13 12:30		Discussion Draft for Cures 2.0 Starts Making the Rounds
2021-08-12 12:30		Proposed $26 Billion Global Opioid Settlement Unveiled
2021-08-11 12:30		Abbott Laboratories Settles Kickback Allegations for $160 Million
2021-08-10 12:30		PhRMA Announces Updated Code on Interactions with Health Care Professionals – Changes include alcohol ban and end to high end restaurants
2021-08-09 12:30		Major Medical Societies Request Delay in Implementation of ACCME New Standards for Integrity and Independence in Accredited Continuing Education
2021-08-06 12:30		Opinion Editorial: Why Should We Rescue The Legislative Intent Of The BPCIA?
2021-08-05 12:30		Arkansas Prohibits Manufacturers from Offering Discounts on Insulin Products
2021-08-04 12:30		OPDP To Study Promotion of Prescription Drugs at HCP Conferences
2021-08-03 12:30		Oregon Enacts Pharmaceutical Representative Licensure & Disclosure Law
2021-08-02 12:30		CMS Releases Proposed Medicare Physician Fee Schedule Payment Rule for CY 2022

<< Archive Index • Subscribe >>